Biomecite’s IBD Diagnostic Tool to Be Evaluated in Proof of Concept Study

Biomecite’s IBD Diagnostic Tool to Be Evaluated in Proof of Concept Study
Biomecite Diagnostics, LLC, a medical diagnostics company, recently announced that it is enrolling patients for a proof of concept study whose goal is to assess the accuracy of a new diagnostic technology for inflammatory bowel disease (IBD). Biomecite’s IBD diagnostic tool is based on a microbiome signature technology developed at the University of Maryland, Baltimore. It

Knowledge is power when living with IBD.

Get access to the web’s leading IBD news & insights for as little as 16¢/day.
Subscribe or to access all post and page content.

Leave a Comment

Your email address will not be published. Required fields are marked *